T1	PrimaryOutcome 42 98	rate of nucleic acid negativity conversion of SARS-CoV-2
T2	PrimaryOutcome 107 133	negativity conversion time
T3	OutcomeDefinition 168 323	defined as the ratio of patients with negativity nucleic acid testing in FNC group to all patients in FNC group at a certain point in the follow-up process
R1	DefinedAs Arg1:T1 Arg2:T3	
T4	SecondaryOutcome 353 388	improvement rate of chest CT images
T5	SecondaryOutcome 394 452	time required for the body temperature returning to normal
T6	SecondaryOutcome 461 506	improvement in respiratory symptoms and signs
T7	OutcomeDefinition 547 623	defined as a significant reduction in the range of lesions and inflammation.
R2	DefinedAs Arg1:T4 Arg2:T7	
T8	OtherOutcome 739 820	vital signs (heart rate, respiratory rate, systolic pressure, diastolic pressure)
T9	OtherOutcome 822 883	changes in laboratory values (liver function, renal function)
T10	OtherOutcome 889 1111	adverse events (including type, incidence, severity, time and drug correlation, and assessment of severity according to the National Cancer Institute Common Terminology Criteria for Adverse Events [NCI CTCAE], version 5.0)
